Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice.

Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice.
复制标题

DOI:
10.1002/mc.20577
复制
发表时间:
2009-12
影响因子:
4.6
通讯作者:
Harris, Curtis C.
Harris, Curtis C.
中科院分区:
医学2区
文献类型:
--
作者:
Olivo-Marston, Susan E.;Hursting, Stephen D.;Lavigne, Jackie;Perkins, Susan N.;Maarouf, Rami S.;Yakar, Shoshana;Harris, Curtis C.
关键词:

文献摘要

参考文献

被引文献

相似文献

High levels of insulin-like growth factor-1 (IGF-1) have been associated with a significant increase in colon cancer risk. Additionally, IGF-1 inhibits apoptosis and stimulates proliferation of colonic epithelial cells in vitro. Unfortunately, IGF-1 knockout mice have severe developmental abnormalities and most do not survive, making it difficult to study how genetic ablation of IGF-1 affects colon tumorigenesis. To test the hypothesis that inhibition of IGF-1 prevents colon tumorigenesis, we utilized a preexisting mouse model containing a deletion of the igf1 gene in the liver through a Cre/loxP system. These liver-specific IGF-1 deficient (LID) mice display a 50–75% reduction in circulating IGF-1 levels. We conducted a pilot study to assess the impact of liver-specific IGF-1 deficiency on azoxymethane (AOM)-induced colon tumors. LID mice had a significant inhibition of colon tumor multiplicity in the proximal area of the colon compared to their wild-type littermates. We examined markers of proliferation and apoptosis in the colons of the LID and wild-type mice to see if these were consistent with tumorigenesis. We observed a decrease in proliferation in the colons of the LID mice and an increase in apoptosis. Finally, we examined cytokine levels to determine whether IGF-1 interacts with inflammatory pathways to affect colon tumorigenesis. We observed a significant reduction in the levels of 7 out of 10 cytokines that were measured in the LID mice as compared to wild-type littermates. Results from this pilot study support the hypothesis that reductions in circulating IGF-1 levels may prevent colon tumorigenesis and affect both proliferation and apoptosis. Future experiments will investigate downstream genes of the IGF-1 receptor.
DOI: 10.7326/0003-4819-122-1-199501010-00009
发表时间: 1995-01-01
影响因子: 39.2
作者:
LEROITH, D;BASERGA, R;ROBERTS, CT
通讯作者: ROBERTS, CT
DOI: 10.1093/carcin/22.11.1831
发表时间: 2001-11-01
期刊: CARCINOGENESIS
影响因子: 4.7
作者:
Hong, MY;Chapkin, RS;Lupton, JR
通讯作者: Lupton, JR
DOI: 10.1158/0008-5472.can-07-6271
发表时间: 2008-05-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Moore, Tricia;Carbajal, Steve;DiGiovanni, John
通讯作者: DiGiovanni, John
DOI: 10.1016/0092-8674(93)90679-k
发表时间: 1993-10-08
期刊: CELL
影响因子: 64.5
作者:
LIU, JP;BAKER, J;EFSTRATIADIS, A
通讯作者: EFSTRATIADIS, A
DOI: 10.1016/s1096-6374(00)90013-3
发表时间: 2000-04-01
影响因子: 1.4
作者:
Ma, J;Pollak, M;Stampfer, MJ
通讯作者: Stampfer, MJ